Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.037 | 0.9 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |